Carl Zeiss Meditec AG

1AFX

Company Profile

  • Business description

    Carl Zeiss Meditec is one of the largest medical technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.

  • Contact

    Goschwitzer Strasse 51-52
    JenaTH07745
    DEU

    T: +49 3641220115

    https://www.zeiss.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    30 September 2025

    Employees

    5,730

Stocks News & Analysis

stocks

WiseTech result disappoints, but the future looks bright

Markets appear underwhelmed by recent sales growth, however, our kingmaker thesis is intact.
stocks

WOW earnings: Woolworths losing market share, but will catch up to Coles

Woolworths have had a soft start to a challenging year, but Morningstar analyst believes it will eventually catch up to its main competitor.
stocks

Chart of the Week: Largest share price falls during earnings

Opportunities arise when the market overreacts, and good quality companies are mispriced.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,241.100.50-0.01%
CAC 407,780.8436.910.48%
DAX 4024,077.5031.290.13%
Dow JONES (US)45,565.23147.160.32%
FTSE 1009,218.9336.57-0.40%
HKSE24,998.82202.94-0.81%
NASDAQ21,590.1445.870.21%
Nikkei 22542,828.79308.520.73%
NZX 50 Index12,903.0841.240.32%
S&P 5006,481.4015.460.24%
S&P/ASX 2008,980.009.500.11%
SSE Composite Index3,843.6043.251.14%

Market Movers